Funding news
DoMore Diagnostics logo

DoMore Diagnostics Secures $10.

Recently funded · $10.8M GrantHospitals and Health CareNOView source

Get the full DoMore Diagnostics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

DoMore Diagnostics, a company leveraging artificial intelligence to make personalized cancer treatment decisions simple and accessible, has secured a $10.8M grant. The funding round marks a significant development for the firm, which is based on prominent international research.

The company's unique digital biomarkers predict patient outcomes from routine tumor tissue slides, designed for seamless integration into pathologists’ existing workflows. Its lead product, Histotype Px® Colorectal, is a CE-IVDD marked outcome prediction marker for stage II and III colorectal adenocarcinoma, which informs decisions on adjuvant chemotherapy following surgical resection.

Other Norway companies recently funded

View all

Biggest recent AI rounds

Largest funding rounds in AI on Signalbase right now.

#CompanyAmount
1
Nuance Healthcare logo

Nuance Healthcare

United States

$19.7B
2
Anthropic logo

Anthropic

$13.0B
3
OpenAI logo

OpenAI

United States

$13.0B
4
Preferred Networks, Inc. logo

Preferred Networks, Inc.

Japan

¥10.0B
5
AIMAX logo

AIMAX

United Kingdom

$10.0B

Other recent Grant rounds

Companies that recently closed a Grant round.

#CompanyAmount
1
Sixteen South logo

Sixteen South

United Kingdom

$100.0K
2
Inovāt logo

Inovāt

United States

$100.0K
3
Gen2 Energy logo

Gen2 Energy

Norway

$72.8M
4
Utah Broadband logo

Utah Broadband

United States

$23.0M
5
Darkhive logo

Darkhive

United States

$49.7M